Beauty brand McPherson’s denies ASIC case over Dr LeWinn sales forecast
Beauty giant McPherson’s has denied ASIC’s claims that it misled the market and breached its disclosure obligations in 2020, arguing that a document showing sales of its Dr LeWinn’s line were down by $21 million was a draft that couldn’t have been used to revise a financial forecast.
For information on rights and reprints, contact subscriptions@lawyerly.com.au